You searched for "retention"

922 results found

Radiology quiz

We are delighted to introduce something new for the Uroradiology Focus – our very own Jane Belfield has put together a urology imaging quiz with 10 cases designed to grab your interest and test your knowledge. Good luck and let...

An MA in medical education – is it for you?

I have recently completed a three-year MA in medical education at the University of Winchester, which has been an edifying experience. The following article may appeal to readers who are considering such a venture. I have been a consultant for...

The Urology Foundation are looking for a new chair for the Science and Education Committee

An opportunity has arisen for you to bring your expertise to chair the highly regarded Science and Education Committee (SEC) of The Urology Foundation.

Minze Uroflow System

Minze Uroflow System with Bluetooth makes it possible for men, women and children with LUTs and bladder dysfunction to be assessed, diagnosed and monitored remotely in the comfort of their homes.

Vasectomy Find: The UK’s #1 lead generation platform for urology services

Vasectomy Find is transforming how urologists grow their private practices. As the UK’s only dedicated lead generation platform for urology, we connect patients actively searching for private urology services directly with trusted urologists like you. Each enquiry we share is...

In conversation with James Green

We were delighted to catch up with James Green, Consultant Urological Surgeon and new President of the Royal Society of Medicine Section of Urology. Can you tell us a little bit about what led you into the field of urology...

Is laparoscopic urological training in Sub-Saharan Africa a goal worth pursuing? Observations from my experience with IVUmed in Senegal

Laparoscopic surgery has developed at an unimaginable pace over the last three decades. The first laparoscopic cholecystectomy was performed by Dr Phillip Mouret in France in 1987, with the first series of 63 cases published in 1989 [1]. However, its...

Upper Tract Developmental Abnormalities

Case 1 1. What is the abnormality and how common is it? 2. What is the embryological origin? 3. With what other conditions can this be associated? Case 2 1. What is the diagnosis and how common is it? 2....

New £1.9M drug trial could delay relapse for prostate cancer patients

A new drug could keep cancer under control for longer for men with advanced prostate cancer and will be tested in a new trial funded with £1.9 million from Prostate Cancer UK. Current treatments, like chemotherapy or hormone-targeting therapies, can...

JCST, GMC, HEE and SACs: how this alphabet soup translates into a seven-year urology training programme

As many trainees will know, and I count myself among them, there are a plethora of organisations involved in our training. Most of us will be familiar with our deaneries, the haven we return to once a month for our...

Advanced prostate cancer and chemotherapy

The treatment pathway for advanced prostate cancer is both puzzling and complex and varies from centre to centre in the UK. The National Prostate Cancer Audit Report 2019 for England and Wales shows that only a quarter of men with...

Cystitis Unmasked

Cystitis is often viewed as a heartsink diagnosis, and sometimes one of exclusion. The aetiology is multifactorial and misunderstood. Treatment has been based on dogma, and poor clinical and scientific evidence. The truth is, that despite the significant morbidity caused...